Unusually comprehensive studies of pulmonary function in hypertensive patients during left ventricular failure and cardiac asthma are presented. These findings are compared to those in mitral stenosis with congestive failure and in pulmonary emphysema with right heart failure. All patients were severely dyspneic and bedridden.
patients were severely dyspneic and bedridden.
ALTHOUGH Harrison1 and others have presented detailed studies of blood gases in left heart failure and cardiac asthma, and a number of papers on the experimental production of cardiac asthma and pulmonary edema are available,2 there are no complete studies of the markedly abnormal respiratory patterns in this state. McCann3 in a recent review has referred to the elevation of arterial pCO2 in the later stage of cardiac decompensation as "replacing the initial hypocapnia." Rodbard4 has emphasized the importance of bronchospasm in cardiac asthma. Our study will attempt to describe the respiratory pattern of left-sided heart failure in an effort to define the physiologic characteristics of such a state. Particular attention will be paid to the respiratory defects found in those patients with cardiac asthma. Studies of the respiratory patterns in mitral stenosis and in emphysema will be used for comparison and contrast.
MATERIAL AND METHODS*
Eight patients with hypertensive heart disease in congestive failure (group I), 14 patients with rheumatic heart disease, mitral stenosis, and congestive failure (group II), and 16 patients with emphysema and right heart failure (group III) were subjected to an evaluation of their pulmonary function. The This work was supported in part by grants from the Los Angeles County Heart Association, the Los Angeles County Tuberculosis and Health Association, the Attending Staff Association of the Los Angeles County Hospital, and the Kalash Vitamin Corporation.
* See Appendix for definitions of terms.
patients were selected specifically for their severe degree of dyspnea, irrespective of the presence or absence of wheezy respiration. All were bedridden at the time of examination. The usual lung volume studies were obtained, and analyses of distribution and diffusion were performed according to the technics of Riley and co-workers.5 In addition, arterial oxygen saturations following positive pressure breathing, exercise, and 100 per cent oxygen were obtained in some of the patients. The expiratory flow pattern was analyzed by recording a pneumotachogram simultaneously with expiratory PO2 and CO2 curves, with both an infrared analyzer and a Beckman mass spectrometer. The mass spectrometer furnished information on alveolar oxygen, alveolar carbon dioxide, and pulmonary clearance. The linearity of response with gas concentration, the rapid inherent response time of the instrument, and its ability to monitor all respiratory gases consecutively rendered it invaluable.
RESULTS
The results of the ventilatory pulmonary function studies in all 3 groups are summarized in table 1 . Because of the non-normal distribution of the data the measurements are summarized as medians in each category and noinparametric tests of statistical significance, in the analysis of variance and the 95 per cent confidence limits, were utilized.6 In table 1, patients in group I (hypertensive heart disease with congestive heart failure) show a marked reduction in vital capacity, maximum breathing capacity, air velocity index, and breathing reserve expressed as a per cent of maximum breathing capacity. In these 4 categories the hypertensive patients are significantly different from the patients with rheumatic heart disease. The ventilatory abnormalities in the hypertensive group are obstructive in nature. patients in group II (rheumatic heart disease and mitral stenosis with congestive heart failure) have only a moderate ventilatory impairment; moreover, they show none of the bronchospastic features present in the hypertensive patient. This is more clearly brought out by the significantly higher ventilation factor in the patients with rheumatic heart disease. The ventilation factor of Motley7 averages 3 measurements: maximum breathing capacity, timed vital capacity, and residual air, expressed as a per cent of the predicted value in each case.
As expected, the patients in group III (emphysema with right heart failure) show marked differences from the group with mitral stenosis and congestive failure. The characteristic ventilatory defects in emphysema are clearly depicted in table 1 Because of such differences, analyses of ventilatory and respiratory measurements in heart failure must take into consideration the underlying etiologic states. In the past, many authors studied lung volumes in heart disease as a whole. Richards and associates,8 for example, measured the lung volumes of patients with congestive heart failure, regardless of etiology. These authors stated that as heart failure progressed, the complementary air diminished markedly, the reserve air became smaller than normal, with a marked decrease in vital capacity, and in extreme failure, the functional residual air was also smaller than the normal. Evidence w-as presented that increased heart size was an important factor in the production of these changes. No differentiation was made between hypertensive, coronary, or rheumatic heart failure.
The studies presented in table 1 emphasize the dissimilarities present in the 2 cardiac groups, particularly the markedly bronchospastic respiration characteristic of the hypertensive patient, and the lower vital capacity, breathing reserve and maximum breathing capacity found in group I.
The specific entity "cardiac asthma" was studied by Harrison,1 who emphasized the marked decrease in vital capacity and concomitant increase in ventilation present in this state. Heyer9 studied 11 patients with cardiac asthma; 3 had cardiac asthma due to syphilitic aortic insufficiency, 4 had hypertensive heart disease, 2 had arteriosclerotic heart disease, and 2 had rheumatic heart disease with mitral stenosis. The spirograms in these patients were identical to those taken on patients with bronchial asthma. Prolongation of expiration was present in both conditions. The expiratoryinspiratory ratio (in seconds) was 1.61 in the normal; in cardiac asthma it was 2.67, and in bronchial asthma it was 2.14. Patients who did not show prolonged wheezing on physical examination might still have a prolongation of expiration well above the normal range. Patients with cardiac asthma improved after receiving aminophylline, with a definite increase in vital capacity. Quite similar findings were reported by Plotz,'0 who studied 9 patients; 5 had cardiac asthma due to hypertensive heart disease, 3 had cardiac asthma due to coronary heart disease, and only 1 had cardiac asthma due to rheumatic heart disease. These 9 patients were given epinephrine. The Frank and co-workers' stressed the increasing minute ventilation in this condition and pointed out that effective alveolar ventilation was maintained throughout all stages of disability. These authors re-emphasized the absence of obstructive defect. Richards12 emphasized the discrepancy between the very moderate degree of ventilatory impairment and the marked degree of exertional dyspnea.
The relation between gas exchange and ventilation has been considered an important measurement of the degree of disability and has been employed to evaluate the cardiac element in dyspnea. McMichael,'4 for example, noted a poor correlation between vital capacity and cardiac output but an excellent inverse correlation between the ventilatory equivalent for carbon dioxide and cardiac output. This was particularly useful in measuring sequential changes in the same patient. He considered the ventilatory equivalent for carbon dioxide more critical than that for oxygen, since it was less dependent upon the respiratory quotient. Frank and co-workers" and Lindgrenl5 found an increased ventilatory equivalent for oxygen in mitral stenosis, but there was no relationship between the ventilatory equivalent and the degree of disability.
In the 3 groups studied in this laboratory, the only significant measurement related to gas exchange on exercise was the change in "true" oxygen on exercise. Patients with emphysema were able to increase the amount of oxygen extracted from inspired air slightly, although the increase was not a normal one. On the other hand, patients in the rheumatic group showed a significant decrease in "true" oxygen on exercise. Measurements of ventilatory equivalents were not conclusive, although all were somewhat elevated at rest. Because of the unstable cardiorespiratory state of most of these patients it would seem likely that a derived measurement so dependent upon ventilation would have greater variability than the per cent change in "true" oxygen on exercise.
Several authors have studied blood gas exchange in heart disease. Varnauskas 1 patient with rheumatic heart disease and 1 patient with hypertensive heart disease, both in pulmonary edema. The ratio of physiologic dead space to tidal volume was somewhat higher in the hypertensive than in the rheumatic group in our series. Finally, the small group of patients with hypertensive heart disease and the severest degree of cardiac asthma deserves special mention. The presence of CO2 retention in cardiac asthma has not been previously emphasized, although Peters and Barr20 had found increases of arterial pCO2 up to 52 mm. in cardiac asthma. McCann3 believed that the initial hypocapnia in heart disease was replaced by elevation of the arterial pCO2 as congestive failure became more severe. It seems most significant that those with the most pronounced degree of cardiac asthma had the lowest vital capacities and the highest arterial pCO2 in the cardiac groups. This small group strongly resembled the patients with emphysema and right heart failure. Nevertheless their arterial oxygen saturation was minimally reduced, an effect that may have been due to the positive pressure effect of bronchospastic respiration.
SUMMARY
In hypertensive heart disease with congestive heart failure, a marked reduction is present in vital capacity, maximum breathing capacity, air velocity index, and breathing reserve expressed as a per cent of maximum breathing capacity. Although not all of the patients complained of the wheezing characteristic of cardiac asthma, the majority of the patients with hypertensive heart disease in failure have an obstructive type of ventilatory impairment. Minimal abnormalities of diffusion, moderate increases in the physiologic dead space and minimal increases in the per cent venous admixture are present. Only in an occasional patient with frank pulmonary edema is marked arterial desaturation present. When cardiac asthma is severe, the vital capacity and maximum breathing capacity are markedly reduced, and true respiratory insufficiency with CO2 retention ensues.
In rheumatic heart disease, mitral stenosis and failure, at a comparable level of disability, only moderate ventilatory impairment exists.
The vital capacity is the measurement that most clearly reflects the ventilatory disability and obstructive ventilatory features are extremely rare. Ventilation tends to be greater than in hypertensive heart disease and thus the aeration gradient is significantly lower. The arterial pCO2 is significantly reduced below the normal range. Greater abnormalities of diffusion are present than in the hypertensive group, and there is also an increase in the ratio of physiologic dead space to tidal volume. Significant arterial oxygen desaturation is rare.
Patients with pulmonary emphysema at a comparable level of disability follow the known established patterns of respiratory impairment. There is a marked increase in residual air, and the obstructive ventilatory insufficiency strongly resembles the pattern found in hypertensive heart disease. However, the transfer gradient and per cent venous admixture are both far greater than in hypertensive heart disease, the arterial pCO2 is higher and arterial oxygen saturation is lower than in cardiac patients with congestive failure. Thus blood gas measurements rather than ventilatory measurements more adequately separate the cardiac and pulmonary groups.
CONCLUSIONS
The characteristic respiratory pattern in patients with hypertensive heart disease with congestive failure and with cardiac asthma is one of obstructive ventilatory insufficiency, low vital capacity and maximum breathing capacity, minimal arterial oxygen desaturation, and arterial pCO2 retention. In contrast, patients with mitral stenosis and congestive failure show hyperventilation, only moderate ventilatory impairment with no obstructive features, and a low arterial pC02. Patients with pulmonary emphysema, at a comparable level of disability, show a higher residual air and a lower breathing reserve. There is a greater degree of arterial oxygen desaturation, a far higher transfer gradient, a larger increase in per cent venous admixture, and a higher arterial pCO2 than in patients with heart disease and congestive failure. ACKNOWLEDGMENT APPENDIX-DEFINITIONS 1. Vital capacity is the maximal volume of gas that can be expelled from the lungs by forceful effort following a maximal inspiration (ml.).
2. Inspiratory reserve volume (formerly complemental air) is the maximal amount of gas that can be inspired from the end-inspiratory position (ml.).
3. Expiratory reserve volume (formerly reserve or supplemental air) is the maximal volume of gas that can be expired from the end-expiratory level (ml.). 4. Residual volume is the volume of gas remaining in the lungs at the end of a maximal expiration, customarily expressed as a per cent of the total capacity (ml.).
5. Maximal breathing capacity is the maximal volume of gas that a subject can breath out per minute, usually measured over a 15-second interval (L./min.). 6 . Air velocity index is the per cent predicted maximum breathing capacity divided by the per cent predicted vital capacity.
7. Tidal volume is the volume of gas inspired or expired during each respiratory cycle (ml.). 11. Timed vital capacity is the volume of the total vital capacity expired in 3 seconds, expressed as a per cent of the vital capacity.
12. Breathing reserve as a per cent of maximum breathing capacity is the maximum breathing capacity minus resting ventilation divided by the maximum breathing capacity.
13. Ventilation factor is an average of (1) the 3-second timed vital capacity as a per cent of predicted vital capacity; (2) the maximum breathing capacity as a per cent of its predicted value; and (3) the normal residual air as a per cent of total lung volume divided by the observed residual air as a per cent total lung volume.
14. Aeration gradient is the P02 of inspired air minus the PO2 of the alveolar air.
15. Transfer gradient is the P02 of alveolar air minus the P02 of arterial blood. 16 . Venous admixture is the quantity of mixed venous blood reaching the peripheral arterial blood from right to left shunts such as bronchial and thebesian veins and abnormally from capillary blood in alveoli in which ventilation is reduced in relation to perfusion. It is expressed as a per cent of cardiac output.
17. Oxygen diffusing capacity is a measure of the permeability to oxygen of the alveolo-capillary membrane of the lung as a whole. The oxygen intake per minute divided by the calculated mean oxygen pressure gradient along the length of the capillary is the oxygen diffusing capacity, expressed as ml. oxygen per minute per mm. Hg.
18. True oxygen is the amount of oxygen extracted from inspired air, expressed in per cent per liter of expired air.
19. Ventilatorv equivalent for carbon dioxide (or oxygen) is the minute volume of air in liters divided by each 100 ml. of oxygen consumed or carbon dioxide produced.
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I affirm likewise of the blood in the veins, that the blood does always, and every where, run out of the lesse into the greater, and hastens towards the heart from every part: whence I gather that whatsoever quantity which is continually sent in, the arteries do receive by the veins, that the same does return and does at last flow back thither from whence it is first driven, and that by this means the blood moves circularly, being driven in its flux and reflux by the heart, by whose force it is driven into all the fibres of the arteries, and that it does afterwards successively by a continuall flux return through the veins, from all those parts which draw, and streyn it through; sense it self teaches us that this is true, and collections from things obvious to sense takes away all occasion of doubt.-WILLIAM HARVEY, De Circulatione Sanguinis, 1649.
